Maravai LifeSciences Holdings, Inc. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Maravai LifeSciences Holdings, Inc. (MRVI) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $64.74 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-02-26
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $64.74M.
- 2024-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $70.06M.
- 2023-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $75.38M.
- 2023-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $76.66M.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2025-12-31 | $64.74M 10-K · filed 2026-02-26 |
| 2024-12-31 | $70.06M 10-K · filed 2026-02-26 |
| 2023-12-31 | $75.38M 10-K · filed 2025-03-18 |
| 2023-09-30 | $76.66M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $80.57M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $30.31M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-29 |